Cargando…
The Evaluation of Clinical and Cost Outcomes Associated with Earlier Initiation of Insulin in Patients with Type 2 Diabetes Mellitus
BACKGROUND: The treatment for patients with type 2 diabetes mellitus (T2DM) follows a stepwise progression. As a treatment loses its effectiveness, it is typically replaced with a more complex and frequently more costly treatment. Eventually this progression leads to the use of basal insulin typical...
Autores principales: | Smolen, Harry J., Murphy, Daniel R., Gahn, James C., Yu, Xueting, Curtis, Bradley H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438249/ https://www.ncbi.nlm.nih.gov/pubmed/25166296 http://dx.doi.org/10.18553/jmcp.2014.20.9.968 |
Ejemplares similares
-
Fast‐acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose‐lowering effect compared with insulin aspart
por: Pieber, Thomas R., et al.
Publicado: (2019) -
Initiating insulin therapy in children and adolescents with type 1 diabetes mellitus
por: Wangnoo, Subhash Kumar
Publicado: (2015) -
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses
por: McGlone, Emma Rose, et al.
Publicado: (2020) -
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2017) -
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
por: Detournay, Bruno, et al.
Publicado: (2020)